Lataa...
Disease-Modifying Effects of M(1) Muscarinic Acetylcholine Receptor Activation in an Alzheimer’s Disease Mouse Model
Alzheimer’s disease (AD) is the leading cause of dementia worldwide, and currently no disease-modifying therapy is available to slow or prevent AD, underscoring the urgent need for neuroprotective therapies. Selective M(1) muscarinic acetylcholine receptor (mAChR) activation is an attractive mechani...
Tallennettuna:
| Julkaisussa: | ACS Chem Neurosci |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808561/ https://ncbi.nlm.nih.gov/pubmed/28230352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.6b00278 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|